GGrantIndex
← Leaderboards

Peter Jesse Gaskill

Albert Einstein College Of Medicine

$6,351,465
Attributed
$7,722,400
Total exposure
7
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.4M · FY200825
$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$7,722,400 · 7

By mechanism

R01$4,680,620 · 2
R61$1,142,172 · 1
K01$727,684 · 1
R33$677,147 · 1
R21$430,375 · 1
F32$64,402 · 1

Top collaborators

Others in their field

Top investigators on “Brain

Research focus

BrainInfectionMacrophageMediatingCellsNeuroinflammationPharmaceutical PreparationsNeuropathologyDopamineDopamine ReceptorProductionHiv InfectionsVirusNeuropathogenesisMicrogliaViralNeuraxisInflammatoryResponseExtracellularAffectDrug AbuserDrug AbuseNeuroaids

Grant awards (24)

Benzodiazepine mediated mechanisms of transcriptional semi-quiescence in discrete myeloid populations$682,249
R01 · FY2025 · DA · contact PI
Defining molecular mechanisms by which stimulant evoked dopamine drives inflammation and neuronal dysfunction in neuroHIV$677,147
R33 · FY2025 · DA · contact PI
Benzodiazepine mediated mechanisms of transcriptional semi-quiescence in discrete myeloid populations$682,249
R01 · FY2024 · DA · contact PI
Defining molecular mechanisms by which stimulant evoked dopamine drives inflammation and neuronal dysfunction in neuroHIV$571,893
R61 · FY2024 · DA · contact PI
Benzodiazepine mediated mechanisms of transcriptional semi-quiescence in discrete myeloid populations$682,249
R01 · FY2023 · DA · contact PI
Defining molecular mechanisms by which stimulant evoked dopamine drives inflammation and neuronal dysfunction in neuroHIV$570,279
R61 · FY2023 · DA · contact PI
Benzodiazepine mediated mechanisms of transcriptional semi-quiescence in discrete myeloid populations$695,124
R01 · FY2022 · DA · contact PI
DAT-Psychostimulant mediated dopamine release increases macrophage IL-1beta production through NF-kB activation and inflammasome priming$195,625
R21 · FY2021 · DA · contact PI
DAT-Psychostimulant mediated dopamine release increases macrophage IL-1beta production through NF-kB activation and inflammasome priming$234,750
R21 · FY2020 · DA · contact PI
Mechanisms of dopamine mediated increase in HIV infection of macrophages$386,109
R01 · FY2019 · DA · contact PI
Mechanisms of dopamine mediated increase in HIV infection of macrophages$386,109
R01 · FY2018 · DA · contact PI
Mechanisms of dopamine mediated increase in HIV infection of macrophages$400,234
R01 · FY2017 · DA · contact PI
Mechanisms of dopamine mediated increase in HIV infection of macrophages$378,947
R01 · FY2016 · DA · contact PI
Mechanisms of dopamine mediated increase in HIV infection of macrophages$333,008
R01 · FY2015 · DA · contact PI
Mechanisms of dopamine mediated increase in HIV infection of macrophages$32,279
R01 · FY2015 · DA · contact PI
Mechanisms of dopamine mediated increase in HIV infection of macrophages$22,063
R01 · FY2015 · DA · contact PI
Dopamine Exacerbates NeuroAIDS by Activation of Macrophage Dopaminergic System$140,181
K01 · FY2014 · DA · contact PI
Dopamine Exacerbates NeuroAIDS by Activation of Macrophage Dopaminergic System$5,892
K01 · FY2014 · DA · contact PI
Dopamine Exacerbates NeuroAIDS by Activation of Macrophage Dopaminergic System$146,073
K01 · FY2013 · DA · contact PI
Dopamine Exacerbates NeuroAIDS by Activation of Macrophage Dopaminergic System$146,073
K01 · FY2012 · DA · contact PI
Dopamine Exacerbates NeuroAIDS by Activation of Macrophage Dopaminergic System$146,073
K01 · FY2011 · DA · contact PI
Dopamine Exacerbates NeuroAIDS by Activation of Macrophage Dopaminergic System$143,392
K01 · FY2010 · DA · contact PI
Macrophages and dopamine: a role in NeuroAIDS$14,756
F32 · FY2009 · DA · contact PI
Macrophages and dopamine: a role in NeuroAIDS$49,646
F32 · FY2008 · DA · contact PI